2022
Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection
Viera A, Grau L, Fisher J, Farnum S, Tetrault J, Scott G, Heimer R. Development and pilot-testing of a hepatitis C reinfection prevention intervention for patients in treatment for hepatitis C infection. Drug And Alcohol Dependence Reports 2022, 3: 100038. PMID: 36845980, PMCID: PMC9948939, DOI: 10.1016/j.dadr.2022.100038.Peer-Reviewed Original Research
2009
Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users
Grau LE, Green TC, Singer M, Bluthenthal RN, Marshall PA, Heimer R. Getting the message straight: effects of a brief hepatitis prevention intervention among injection drug users. Harm Reduction Journal 2009, 6: 36. PMID: 20003518, PMCID: PMC2804675, DOI: 10.1186/1477-7517-6-36.Peer-Reviewed Original ResearchRisk reduction materialsSyringe exchange programsInjection drug usersHygiene suppliesDrug usersHealth promotion behaviorsAppropriate useHealth promotion materialsSEP clientsPrevention interventionsHepatitis riskBlood flowInjection practicesPromotion behaviorsInjection siteBrief interventionIntervention effectivenessIntervention packetInterventionPassive introductionPromotion materialsExchange programsOne-quarterSubstantial numberVerbal reminders
2008
Social and structural aspects of the overdose risk environment in St. Petersburg, Russia
Green TC, Grau LE, Blinnikova KN, Torban M, Krupitsky E, Ilyuk R, Kozlov A, Heimer R. Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. International Journal Of Drug Policy 2008, 20: 270-276. PMID: 18774283, PMCID: PMC2696401, DOI: 10.1016/j.drugpo.2008.07.002.Peer-Reviewed Original ResearchConceptsDrug usersRisk behaviorsIntervention feasibilityOpioid overdosesModerate-risk behaviorAbstinence-based treatmentMost drug usersOpioid injectorsSuboptimal responseOverdose response trainingTreatment modalitiesCommon causeOverdose riskNaloxone distributionOverdose mortalityModifiable aspectsAmbulance staffRisk environmentOverdosesTreatment providersMortalityStructural interventionsKey informant interviewsMore ambulancesIntervention
2000
Viability of HIV-1 in syringes: implications for interventions among injection drug users.
Heimer R, Abdala N. Viability of HIV-1 in syringes: implications for interventions among injection drug users. The AIDS Reader 2000, 10: 410-7. PMID: 10932845.Peer-Reviewed Original Research